Zepp Health Corp (NYSE:ZEPP)

Q4 2024 Zepp Health Corp Earnings Call Transcript

Mar 26, 2025 / 11:00 PM GMT

Release Date Price: $3 (-6.83%)

Transcript

Key Points

Positve

Zepp Health Corp (ZEPP) reported a 40% quarter-over-quarter sales increase in Q4 2024, aligning with their guidance.
The company's gross margin for 2024 improved significantly to 39% from 26.2% in 2023.
The successful launch of the T-Rex 3 smartwatch, featuring advanced AI technology, has driven substantial growth and positive market feedback.
Zepp Health Corp (ZEPP) has diversified its product lineup with new launches like the Masfe Active 2, which has received positive reviews.
The company has strategically managed its supply chain to mitigate the impact of US tariffs, with 20-25% of manufacturing now outside China.

Negative

Overall revenue declined year-over-year due to a decrease in Xiaomi product sales and limited new product launches.
The company reported an adjusted operating loss of $7.4 million in Q4 2024, primarily due to lower sales volume.
Net loss for Q4 2024 was $36.9 million, impacted by investment impairments and deferred tax asset valuation allowances.
Zepp Health Corp (ZEPP) faces challenges from macroeconomic issues affecting the global consumer market.
The stock remains illiquid, and the company acknowledges being undervalued in the market.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

ZEPP.N - Zepp Health Corp
Q4 2024 Zepp Health Corp Earnings Call
Mar 26, 2025 / 11:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Hello, ladies and gentlemen.

Thank you for standing by for Zent Health Corporation's fourth quarter and full year 2024 earnings conference call.

At this time, all participants are in listen-only mode.

Today's conference call is being recorded.

I will now turn the call over to your host, Ms. Grace Zong, director of investor relations for the company. Please go ahead, Grace.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Hello everyone and welcome to Deb House Corporation's 4th quarter and full year 2024 earnings conference call. The company's

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.